Biodexa Pharmaceuticals Plc (BDRX) Ownership

NASDAQ: BDRXTop holders, insider trades and short interest.

BDRX ownership summary

as of October 17, 2026
Institutions
0.4%
of shares outstanding
Insiders
0.00%
of shares outstanding
Shares outstanding
2.2M
Float
684K
shares available to trade
Short interest
0.83%
18K shares short
Days to cover
—
short interest down 93.2% vs prior month
  • Institutions 0.37%
  • Other investors 99.63%

BDRX top institutional holders

10 largest
Biodexa Pharmaceuticals Plc top institutional holders
#Holder% of sharesSharesValueChangeReported
1Armistice Capital, LLC0.67%15K$6,753−4,695 (−24.1%)June 30, 2026
2GAMMA Investing LLC0.05%1,203$549+1,203 (0.0%)June 30, 2026
3Allied Private Wealth LLC0.02%489$223+489 (0.0%)June 30, 2026
4SBI Securities Co Ltd<0.01%29$13−1 (−3.3%)June 30, 2026
5UBS Group AG<0.01%25$11—June 30, 2026
6Hilton Head Capital Partners, LLC<0.01%6$3—June 30, 2026
7Caitong International Asset Management Co., Limited.<0.01%5$2+5 (0.0%)June 30, 2026
8Rhumbline Advisers<0.01%3$1−1 (−25.0%)June 30, 2026
9Sabby Management LLC0.00%——−51,494 (−100.0%)June 30, 2026
10HRT FINANCIAL LLC0.00%——−10,583 (−100.0%)March 31, 2026

Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 10, 3 holders added 1,697 shares and 5 cut 67K.

BDRX shares outstanding

Shares outstanding

Year-end shares outstanding, adjusted for splits.

Who owns BDRX

Institutional investors own 0.4% of Biodexa Pharmaceuticals Plc's shares and insiders 0.00%. The largest holder is Armistice Capital, LLC with 0.67% of the shares (15K), as of June 30, 2026. Among the top 10 institutions, 3 added shares and 5 reduced their stake in the latest filings. Short interest is 0.83% of the float. The share count fell 98.2% since 2014.

Related: BDRX analyst forecast, BDRX key metrics. See the BDRX stock overview for the latest quote and news.

BDRX ownership FAQ

Who owns the most Biodexa Pharmaceuticals Plc stock?

The largest shareholders of Biodexa Pharmaceuticals Plc are Armistice Capital, LLC (0.67%), GAMMA Investing LLC (0.05%), Allied Private Wealth LLC (0.02%), SBI Securities Co Ltd (<0.01%), UBS Group AG (<0.01%).

What percentage of Biodexa Pharmaceuticals Plc is owned by institutions?

Institutions hold 0.4% of Biodexa Pharmaceuticals Plc's shares outstanding; insiders hold 0.00%.

What is Biodexa Pharmaceuticals Plc's short interest?

18K shares of Biodexa Pharmaceuticals Plc were sold short, 0.83% of the float.

How many shares of Biodexa Pharmaceuticals Plc are outstanding?

Biodexa Pharmaceuticals Plc has 2.2M shares outstanding, of which 684K are in the public float.

Biotechnology: ownership